Psychopharmacology

Latest News

Here are highlights from the week in Psychiatric Times.
The Week in Review: June 10-14

June 15th 2024

Here are highlights from the week in Psychiatric Times.

What is their comparative safety?
Antipsychotic Polypharmacy vs Monotherapy

June 14th 2024

The CDC suggests that disrupted access to ADHD medications may increase risk of overdose and injury.
CDC Issues HAN Health Advisory Following DOJ Indictment of Digital Health Provider of Adderall

June 14th 2024

Recent research sheds light on which antidepressants should be preferred as a first option for long-term use.
Differences in Long-Term Response Among Antidepressants for MDD

June 12th 2024

Experts shared the study results in a poster presentation at the 2024 ASCP Annual Meeting.
Phase 2b Study Explores Efficacy of MM-120 for the Treatment of GAD

June 10th 2024

Video Interviews
Podcasts
Latest CME Events & Activities

Advances In™ Schizophrenia: Expanding the Therapeutic Landscape

View More

Expert Illustrations & Commentaries™: Visualizing New Therapeutic Targets in Schizophrenia

View More

Southern California Psychiatry Conference

September 13-14, 2024

Register Now!

Updates on New and Emerging Therapies to Improve Outcomes for Patients With Major Depressive Disorder

View More

PER® Psychiatry Summit

November 7, 2024

View More

2023 Annual Psychiatric Times™ World CME Conference

View More

5th Annual International Congress on the Future of Neurology®

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

Real Psychiatry 2025

January 17 - 18, 2025

View More

More Than ‘Blue’ After Birth: Managing Diagnosis and Treatment of Post-Partum Depression

View More

Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans

View More

Expert Perspectives in the Recognition and Management of Postpartum Depression

View More

More News

© 2024 MJH Life Sciences

All rights reserved.